SCHEMBL4889421

SCHEMBL4889421

CCOC(=O)CC(CNC(=O)O)CC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
GAA P10253 2/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
CACNA2D1 P54289 2/20 0.37
CACNB3 P54284 1/20 0.37
CACNA1C Q13936 1/20 0.37
PGR P06401 1/20 0.37
ADRA1A P35348 1/20 0.37
HTR2B P41595 1/20 0.37
CACNA2D2 Q9NY47 1/20 0.37
ALDH1A1 P00352 4/20 0.34
TRPA1 O75762 1/20 0.34
TSHR P16473 3/20 0.34
CYP3A4 P08684 2/20 0.33
ALOX15 P16050 2/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889414 1.00 CYP2D6 (0.47) CYP2D6CYP2C19GAAMGAMSI
SCHEMBL4885742 0.89 CYP2D6 (0.43) CYP2D6CYP2C19CACNA2D1CACNB3CACNA1C
SCHEMBL4885745 0.89 CYP2D6 (0.43) CYP2D6CYP2C19CACNA2D1CACNB3CACNA1C
SCHEMBL4887138 0.89 CYP2D6 (0.46) CYP2D6CYP2C19CACNA2D1CACNB3CACNA1C
SCHEMBL4887135 0.89 CYP2D6 (0.46) CYP2D6CYP2C19CACNA2D1CACNB3CACNA1C
SCHEMBL4892333 0.86 CYP2D6 (0.41) CYP2D6CYP2C19ALDH1A1MAPT
SCHEMBL4892337 0.86 CYP2D6 (0.41) CYP2D6CYP2C19ALDH1A1MAPT
SCHEMBL4889416 0.86 CYP2D6 (0.50) CYP2D6CYP2C19CACNA2D1CACNB3CACNA1C
SCHEMBL4889289 0.86 CYP2D6 (0.50) CYP2D6CYP2C19CACNA2D1CACNB3CACNA1C
SCHEMBL22355851 0.85 CYP2D6 (0.48) CYP2D6CYP2C19CACNA2D1CACNB3CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080311635-A1 PROCESS FOR THE PREPARATION OF (S)(+)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID DIPHARMA FRANCIS S.R.L. (IT) 2008-12-18 US claimed
EP-1992609-A1 A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid Dipharma Francis S.r.l. (IT) 2008-11-19 EP claimed
US-20080311635-A1 PROCESS FOR THE PREPARATION OF (S)(+)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID DIPHARMA FRANCIS S.R.L. (IT) 2008-12-18 US disclosed
EP-1992609-A1 A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid Dipharma Francis S.r.l. (IT) 2008-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080311635-A1 PROCESS FOR THE PREPARATION OF (S)(+)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID ADH5, ALDH7A1, ADH1C CYP2D6 35/4885CYP2C19 161/4885GAA 1024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.